Matthew Bowen, Principal Accounting Officer at Monte Rosa Therapeutics, Inc. (GLUE), sold 13 shares at $10.56 ($137) on 2026-10-05, disclosed to the SEC on 2026-10-06.
Open-market sale of $137 GLUE by Principal Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.